$GGAAF
NeuroMind AI Corp.

2023 Q4 Form 10-K Financial Statement

#000121390024020393 Filed on March 06, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $471.2K $120.0K $3.297M
YoY Change -69.01% -96.36% 2895.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $471.2K $120.0K $120.0K
YoY Change -69.01% 0.0% 9.02%
Operating Profit -$1.239M -$3.297M
YoY Change -62.41%
Interest Expense $13.74K $1.660M $3.634M
YoY Change -99.36% -54.31% 534380.88%
% of Operating Profit
Other Income/Expense, Net $25.00K $3.634M
YoY Change -99.31%
Pretax Income -$457.5K $421.4K $337.9K
YoY Change -173.25% 24.71% -408.87%
Income Tax
% Of Pretax Income
Net Earnings -$457.5K $421.4K $337.9K
YoY Change -173.25% 24.71% -408.87%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.07 $0.04 $0.01
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.201M
YoY Change -48.36%
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $208.7K
YoY Change 372.97%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.409M
YoY Change -40.51%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.049M $263.0M
YoY Change -99.6% 2.4%
Other Assets
YoY Change
Total Long-Term Assets $1.049M $263.0M
YoY Change -99.6% 2.4%
TOTAL ASSETS
Total Short-Term Assets $1.409M
Total Long-Term Assets $1.049M $263.0M
Total Assets $1.049M $1.049M $264.4M
YoY Change -99.6% -99.6% 2.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.939M $2.304M
YoY Change 27.57% 620.68%
Accrued Expenses $675.7K
YoY Change 613.25%
Deferred Revenue
YoY Change
Short-Term Debt $2.400M $2.530M
YoY Change -5.12% 1009.26%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.339M $19.42M
YoY Change -72.51% 2923.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.339M $19.42M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.339M $5.339M $19.42M
YoY Change -72.51% -72.51% 33.43%
SHAREHOLDERS EQUITY
Retained Earnings -$5.240M
YoY Change -70.75%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.239M -$4.290M $244.9M
YoY Change
Total Liabilities & Shareholders Equity $1.049M $1.049M $264.4M
YoY Change -99.6% -99.6% 2.01%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income -$457.5K $421.4K $337.9K
YoY Change -173.25% 24.71% -408.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$92.77K -$1.071M -$896.3K
YoY Change -89.65% 19.5% 2652.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $264.8M -$1.406M
YoY Change -100.0% -18936.98% -99.45%
Cash From Investing Activities $0.00 $264.8M -$1.406M
YoY Change -100.0% -18937.05% -99.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $263.6M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 92.77K -$263.7M $2.302M
YoY Change -95.97% -11555.71% -99.11%
NET CHANGE
Cash From Operating Activities -92.77K -$1.071M -$896.3K
Cash From Investing Activities 0.000 $264.8M -$1.406M
Cash From Financing Activities 92.77K -$263.7M $2.302M
Net Change In Cash 0.00000002998 $0.00 $0.00
YoY Change -100.0% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$92.77K -$1.071M -$896.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41138
CY2023 dei Entity Registrant Name
EntityRegistrantName
GENESIS GROWTH TECH ACQUISITION CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1601264
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Bahnhofstrasse 3
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Hergiswil Nidwalden
CY2023 dei Entity Address Country
EntityAddressCountry
CH
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
6052
CY2023 dei City Area Code
CityAreaCode
+41
CY2023 dei Local Phone Number
LocalPhoneNumber
78 607 99 01
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1660450 usd
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1064951 usd
CY2023 dei Auditor Firm
AuditorFirmId
206
CY2023 dei Auditor Name
AuditorName
MaloneBailey, LLP
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
208721 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1409316 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
1048582 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
262960151 usd
CY2023Q4 us-gaap Assets
Assets
1048582 usd
CY2022Q4 us-gaap Assets
Assets
264369467 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2938522 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2979230 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13915000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5339011 usd
CY2022Q4 us-gaap Liabilities
Liabilities
19424230 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
948582 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
262860151 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5239644 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17915547 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5239011 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17914914 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1048582 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
264369467 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1119097 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3176600 usd
CY2023 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
120000 usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
120000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1239097 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-3296600 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
1660450 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3634473 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1660450 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3634473 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
421353 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
337873 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-12187636 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
6065151 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
337873 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17914914 usd
CY2023 ggaa Waiver Of Deferred Underwriting Fee
WaiverOfDeferredUnderwritingFee
13915000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
421353 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5239011 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
421353 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
337873 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
1660450 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3634473 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-208721 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
164588 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-40708 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2564860 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1071084 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-896328 usd
CY2023 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
1200595 usd
CY2022 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
1124405 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2530000 usd
CY2023 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
263572019 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
264772614 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1405595 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
530000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
228077 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
400489 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2530000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
263572019 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-263701530 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2301923 usd
CY2023 ggaa Waiver Of Deferred Underwriting Fee
WaiverOfDeferredUnderwritingFee
13915000 usd
CY2022 ggaa Extension Funds Attributable To Common Stock Subject To Redemption
ExtensionFundsAttributableToCommonStockSubjectToRedemption
2530000 usd
CY2023 ggaa Accretion Of Common Stock Subject To Redemption
AccretionOfCommonStockSubjectToRedemption
1660450 usd
CY2022 ggaa Accretion Of Common Stock Subject To Redemption
AccretionOfCommonStockSubjectToRedemption
6065151 usd
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-03-17
CY2023 ggaa Fair Value Percentage
FairValuePercentage
0.80 pure
CY2023 ggaa Public Share Price
PublicSharePrice
11.64
CY2023 ggaa Dissolution Expenses
DissolutionExpenses
100000 usd
CY2023Q4 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
263325414 usd
CY2023Q4 ggaa Trust Account Per Share
TrustAccountPerShare
10.45
CY2023Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
5883786 shares
CY2023Q3 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.92 pure
CY2023Q3 us-gaap Shares Issued
SharesIssued
6426039 shares
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
6426039 shares
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
246605.4 usd
CY2023 us-gaap Limited Liability Company Llc Or Limited Partnership Lp Predecessor Entity Ies To Business Combination
LimitedLiabilityCompanyLLCOrLimitedPartnershipLPPredecessorEntityIesToBusinessCombination
(i) the Assigned Patent Rights, including the Additional Rights, as such terms are defined in the Patent Purchase Agreement, and (ii) all other intellectual property rights acquired by the Sponsor under the Patent Purchase Agreement, and (b) the Company will pay to the Sponsor one thousand dollars ($1,000) and will assume and agree to perform and discharge all of the Sponsor’s obligations under the Patent Purchase Agreement, including the obligation to pay to MindMaze a purchase price of $21 Million (the “MindMaze IP Purchase Price”) on or prior to May 31, 2024 and the obligation to share certain revenues with MindMaze, on the terms and subject to the conditions set forth in the Patent Purchase Agreement (collectively, the “Transaction”).
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
11.5
CY2023 ggaa Working Capital Deficit
WorkingCapitalDeficit
5300000 usd
CY2023 us-gaap Other Expenses
OtherExpenses
25000 usd
CY2023 us-gaap Payments For Loans
PaymentsForLoans
453000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
0 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
2530000 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
1048582 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
262960151 usd
CY2023Q4 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
263325414 usd
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
10.45
CY2023Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
5883786 shares
CY2023Q3 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.92 pure
CY2023Q3 us-gaap Shares Issued
SharesIssued
6426039 shares
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
6426039 shares
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
246605.4 usd
CY2023Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.63
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
262860151 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
263572019 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Redemption Value
RedeemableNoncontrollingInterestEquityCommonRedemptionValue
1660450 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
948582 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10
CY2021Q4 ggaa Units Issued During Period Shares New Issues
UnitsIssuedDuringPeriodSharesNewIssues
3300000 shares
CY2021Q4 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
825000 shares
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
25000 usd
CY2023 ggaa Number Of Shares Issued
NumberOfSharesIssued
1 shares
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
453000 usd
CY2021Q4 ggaa Notes Payable Related Party Current And Noncurrent
NotesPayableRelatedPartyCurrentAndNoncurrent
200000 usd
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
25000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
228000 usd
CY2022Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2530000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2400489 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2530000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120000 usd
CY2023 ggaa Related Party Transaction Agreement Outstanding
RelatedPartyTransactionAgreementOutstanding
30000 usd
CY2022 ggaa Related Party Transaction Agreement Outstanding
RelatedPartyTransactionAgreementOutstanding
120000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1057397 usd
CY2023Q4 ggaa Underwriting Discount Per Unit
UnderwritingDiscountPerUnit
0.55
CY2023 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
13900000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.20 pure
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
11.5
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.2
CY2023 us-gaap Credit Derivative Liquidation Proceeds Percentage
CreditDerivativeLiquidationProceedsPercentage
0.60 pure
CY2023 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
1.15 pure
CY2023 us-gaap Investment Company Redemption Fee Per Share
InvestmentCompanyRedemptionFeePerShare
18
CY2023 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.01
CY2023 ggaa Class Of Warrant Or Right Exercisable Entity May Redeem Redemption Written Notice Period
ClassOfWarrantOrRightExercisableEntityMayRedeemRedemptionWrittenNoticePeriod
P30D
CY2023Q4 us-gaap Share Price
SharePrice
18
CY2023 ggaa Number Of Trading Days
NumberOfTradingDays
P20D
CY2022Q4 us-gaap Deposit Assets
DepositAssets
2530000 usd
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
CY2022 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2022 ggaa Waiver Of Deferred Underwriting Fee
WaiverOfDeferredUnderwritingFee
usd
CY2023 ggaa Extension Funds Attributable To Common Stock Subject To Redemption
ExtensionFundsAttributableToCommonStockSubjectToRedemption
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001865697

Files In Submission

Name View Source Status
0001213900-24-020393-index-headers.html Edgar Link pending
0001213900-24-020393-index.html Edgar Link pending
0001213900-24-020393.txt Edgar Link pending
0001213900-24-020393-xbrl.zip Edgar Link pending
ea0200956-10k_genesis.htm Edgar Link pending
ea0200956ex31-1_genesisgro.htm Edgar Link pending
ea0200956ex31-2_genesisgro.htm Edgar Link pending
ea0200956ex32_genesisgro.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ggaa-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
ggaa-20231231_def.xml Edgar Link unprocessable
ggaa-20231231_lab.xml Edgar Link unprocessable
ea0200956-10k_genesis_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ggaa-20231231_cal.xml Edgar Link unprocessable
ggaa-20231231_pre.xml Edgar Link unprocessable